Advaxis

+$0.0021 (+0.59%) As of 4:00 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Advaxis and other ETFs, options, and stocks.

About ADXS

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins.

CEO
Kenneth A. Berlin
Employees
18
Headquarters
Princeton, New Jersey
Founded
1987

ADXS Key Statistics

Market cap
52.57M
Price-Earnings ratio
—
Dividend yield
—
Average volume
3.46M
High today
$0.36
Low today
$0.3398
Open price
$0.343
Volume
752.17K
52 Week high
$1.57
52 Week low
$0.2941

ADXS Earnings

-$0.15
-$0.10
-$0.05
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Jan 21, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure